New Zealand markets closed

Progenity, Inc. (PROG)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.3250+0.0450 (+3.52%)
As of 01:46PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 234.16M
Enterprise value 337.40M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.28
Price/book (mrq)N/A
Enterprise value/revenue 4.49
Enterprise value/EBITDA -1.74

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-81.40%
S&P500 52-week change 316.48%
52-week high 37.2600
52-week low 30.6570
50-day moving average 32.4959
200-day moving average 32.3957

Share statistics

Avg vol (3-month) 335.69M
Avg vol (10-day) 313.4M
Shares outstanding 5163.75M
Implied shares outstanding 6N/A
Float 8122.74M
% held by insiders 110.25%
% held by institutions 152.98%
Shares short (13 Jan 2022) 413M
Short ratio (13 Jan 2022) 41
Short % of float (13 Jan 2022) 410.27%
Short % of shares outstanding (13 Jan 2022) 47.94%
Shares short (prior month 14 Dec 2021) 415.53M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-281.17%

Management effectiveness

Return on assets (ttm)-121.42%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)75.07M
Revenue per share (ttm)1.12
Quarterly revenue growth (yoy)225.00%
Gross profit (ttm)-19.12M
EBITDA -206M
Net income avi to common (ttm)-233.14M
Diluted EPS (ttm)-3.4440
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)54.14M
Total cash per share (mrq)0.33
Total debt (mrq)157.83M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.90
Book value per share (mrq)-1.48

Cash flow statement

Operating cash flow (ttm)-198.12M
Levered free cash flow (ttm)-112.24M